new lupus drug
janers
Earlier this month, the promising results of a potential new treatment for lupus -- BENLYSTAT -- were announced. If approved
by the Food and Drug Administration (FDA), BENLYSTA would be the first new lupus treatment in more than 50 years and the
first drug ever developed specifically for lupus.
Now more than ever we need your support. It is critical that we continue to fund our research program to find additional
therapies needed to manage this disease, and find ways to fully restore the quality of life that people with lupus once knew.
While more research is required for FDA approval, the results are encouraging. The study provides new hope for people with
lupus . the type of hope that the LFA continues to advance thanks to supporters like you.
Physicians need a complete arsenal of therapies to provide the individualized treatment that lupus requires. With your help,
we can ensure that they will.
A Giant Leap for Lupus
It is likely that we will all remember July 20, 2009, not only as the anniversary of the first moon landing, but
also when a historic breakthrough in lupus occurred. The Lupus Foundation of America is celebrating the positive results of
BENLYSTAT announced by Human Genome Sciences. Only top-line results of the first of two studies have been released thus far.
Additional details of the results will be presented later this year at a major scientific meeting. In addition, we eagerly
await the results of the longer-term Phase III clinical trial to be released in November when the study is completed.
Until then, the following resources can be used to answer questions you may have.
Frequently Asked Questions regarding BENLYSTAT (Formerly Lymphostat-B)
Should you have additional questions about BENLYSTA, you can contact one of the LFA's health educators at
202-349-1159 or lupu...@lupus.org.